• 대한수의학회지
• /
• 제14권1호
• /
• pp.77-90
• /
• 1974

Hemolytic reaction of normal fresh chicken serum on sheep erythrocytes was studied and the following experimental results were obtained and summarized. 1. Chicken sera, 258 (78%) out of 344 samples showed hemolytic activity on sheep erythrocytes. 2. Distribution of a different hemolytic titer of chicken sera was not dependent to sex and age difference of test chicken. 3. Hemolytic activity of serum component obtained from normal fresh chicken was heat inactivated at $56^{\circ}C$. 30 minutes heating. 4. The most enhanced hemolytic activity of chicken serum on sheep erythrocytes was observed at the incubation temperature of $46^{\circ}C$. 5. The most effective pH for the hemolytic reaction of chicken serum on sheep erythrocytes was observed at 7.0, and pH 6.0 or 8.5 resulted less or no hemolysis. 6. Hemolytic reaction of chicken serum and sheep erythrocytes required Mg⧻ and Ca⧻ ions as, co-factor, and the former was required more compared to the latter. 7. Hemolytic activity of chicken serum was observed in ChC 2, 4 fraction but not in ChC 1, 3, ChC 3, 4, ChC 1, 2, 4 and ChC 1, 2, 3 fractions. 8. In electron micrography, morphological changes of sheep erythrocyte membrane by normal chicken serum was similar to that of immune hemolysis: that was, the hemolytic hole was circular and it was surrounded with a white ring. 9. Electron micrography of morphological changes on sheep erythrocyte membrane indicated that the size of hemolytic hole and white ring were functional to the chicken serum concentration used and reaction time.

• Neonatal Medicine
• /
• 제15권2호
• /
• pp.190-195
• /
• 2008

저자들은 항-E항체에 의한 신생아 동종 면역성 용혈성 질환 환아에서 생후 8일째 담낭내 오니가 있고 4개월, 9개월, 11개월 및 50개월 후 추적 초음파에서 담석을 보인 1례를 경험하였기에 보고하는 바이다

• Childhood Kidney Diseases
• /
• 제24권2호
• /
• pp.138-142
• /
• 2020

Atypical hemolytic uremic syndrome (aHUS) is an extremely rare and life-threatening disorder. Typical HUS is often caused by Shiga toxin-positive Escherichia coli, while aHUS is caused by dysregulation of the alternative pathway of the complement system in association with genetic abnormalities or development of autoantibodies. Eculizumab, a humanized anti-complement 5 monoclonal antibody, is recommended for the treatment of aHUS, but its long-term safety and efficacy in pediatric patients remain under review. In this paper, we report a pediatric case of aHUS with anti-complement factor H autoantibodies, who was treated successfully with eculizumab.

• Childhood Kidney Diseases
• /
• 제23권1호
• /
• pp.43-47
• /
• 2019

Atypical hemolytic uremic syndrome (aHUS), a rare form of thrombotic microangiopathy, is distinguished from the typical form by the absence of a preceding verotoxin-producing Escherichia coli infection. Notably, aHUS occurs in association with genetic or acquired disorders causing dysregulation of the alternative complement pathway. Patients with aHUS may show the presence of anti-complement factor H (CFH) autoantibodies. This acquired form of aHUS (antiCFH-aHUS) primarily affects children aged 9-13 years. We report a case of a 13-year-old Lao girl with clinical features of aHUS (most likely anti-CFH-aHUS). The initial presentation of the patient met the classical clinical triad of thrombotic microangiopathy (microangiopathic hemolytic anemia, thrombocytopenia, and acute kidney injury) without preceding diarrheal illness. Low serum levels of complement 3 and normal levels of complement 4 indicated abnormal activation of the alternative complement pathway. Plasma infusion and high-dose corticosteroid therapy resulted in improvement of the renal function and hematological profile, although the patient subsequently died of infectious complications. This is the first case report that describes aHUS (possibly anti-CFH-aHUS) in Laos.

• Childhood Kidney Diseases
• /
• 제26권1호
• /
• pp.58-62
• /
• 2022

Atypical hemolytic uremic syndrome (aHUS) is a rare disease characterized by microangiopathic hemolytic anemia, thrombocytopenia, and acute kidney injury without any association with preceding diarrhea. Dysregulation of the complement system is the most common cause of aHUS, and monoclonal humanized anti-C5 antibodies are now recommended as the first-line treatment for aHUS. However, if the complement pathway is not the cause of aHUS, C5 inhibitors are ineffective. In this study, we report the second reported case of aHUS caused by DGKE mutations in Republic of Korea. The patient was an 11-month-old infant who presented with prodromal diarrhea similar to typical HUS, self-remitted with conservative management unlike complement-mediated aHUS but recurred with fever. While infantile aHUS often implies genetic dysregulation of the complement system, other rare genetic causes, such as DGKE mutation, need to be considered before deciding long-term treatment with C5 inhibitors.

• Clinical and Experimental Pediatrics
• /
• 제50권10호
• /
• pp.931-937
• /
• 2007

The hemolytic uremic syndrome (HUS) is a rare disease of microangiopathic hemolytic anemia, low platelet count and renal impairment. HUS usually occurs in young children after hemorrhagic colitis by shigatoxin-producing enterohemorrhagic E. coli (D+HUS). HUS is the most common cause of acute renal failure in infants and young children, and is a substantial cause of acute mortality and morbidity; however, renal function recovers in most of them. About 10% of children with HUS do not reveal preceding diarrheal illness, and is referred to as D- HUS or atypical HUS. Atypical HUS comprises a heterogeneous group of thrombomicroangiopathy (TMA) triggered by non-enteric infection, virus, drug, malignancies, transplantation, and other underlying medical condition. Emerging data indicate dysregulation of alternative complement pathway in atypical HUS, and genetic analyses have identified mutations of several regulatory genes; i.e. the fluid phase complement regulator Factor H (CFH), the integral membrane regulator membrane cofactor protein (MCP; CD46) and the serine protease Factor I (IF). The uncontrolled activation of the complement alternative pathway results in the excessive consumption of C3. Plasma exchange or plasma infusion is recommended for treatment of, and has dropped the mortality rate. However, overall prognosis is poor, and many patients succumb to end-stage renal disease. Clinical presentations, response to plasma therapy, and outcome after renal transplantation are influenced by the genotype of the complement regulators. Thrombotic thrombocytopenic purpura (TTP), another type of TMA, occurs mainly in adults as an acquired disease accompanied by fever, neurologic deficits and renal abnormalities. However, less frequent cases of congenital or hereditary TTP associated with ADAMTS-13 (a disintegrin and metalloprotease, with thrombospondin 1-like domains 13) gene mutations have been reported, also. Recent advances in molecular genetics better allow various HUS to be distinguished on the basis of their pathogenesis. The genetic analysis of HUS is important in defining the underlying etiology, predicting the genotype-related outcome and optimizing the management of the patients.

• 한국동물학회지
• /
• 제34권1호
• /
• pp.20-30
• /
• 1991

지렁이(L. rubelIus) 체액내의 적혈구용혈능깍 단백질분해능을 확인하였다. 지렁이의 체액 0. 33 $\mu$l속에 있는 용혈인자는 9 $\times$ 1011 rat RBCs를 2분만에 완전히 용혈시켰으며, 다른 포유류들의 적혈구에도 약간의 차이는 있으나 비슷한 용혈능을 보였고, 이 용혈인자는 지렁이의 혈구가 아닌 몸체조직에서 분비되는 것으로 생각되었다. 용혈인자는 pH 6.5-7.5사이에서 활성이 가장 강하였고, 63'c로 30분 열처리할 경우 활성이 완전히 없어졌으며, 2-mercaptoethanol은 용혈인자의 활성을 증가시켰다. 이 인자의 활성도는 여러가지의 당류, LPS, cholesterol, prosphatidyl Choline, Ch10ropromazine, Sphin90myelin 및 FG2+, Fe3+, CU2+, ZR2+ 등의 금속이온에 의하여 활성이 저해되었다. 한편 지렁이 체액내의 단백질 분해인자는 BSA와 19G를 여러 조각으로 분해시켰으며 이 분해인자는 PMSF및 TLCK에 의하여 활성이 억제되지 않았다. 지렁이의 체강에는 용혈소를 분비하는 박테리아들이 존재하였으나 이들 박테리아들의 용혈소는 지렁이의 용혈인자와는 전기영동이동도에서 차이가 있었다.

• KSBB Journal
• /
• 제31권4호
• /
• pp.228-236
• /
• 2016

The aim of this study was to characterize the hemolytic Aeromonas sp. MH-8 exposed to green tea catechin, epigallocatechin gallate (EGCG). Initially, the hemolytic Aeromonas sp. MH-8 was enriched and isolated from stale fish. Bactericidal effects of MH-8 exposed to EGCG ranging from 1 mg/mL to 4 mg/mL were monitored, and complete bactericidal effects were achieved within 3 h at 3 mg/mL and higher concentrations. SDS-PAGE with silver staining revealed that the amount of lipopolysaccharides increased or decreased in the strain MH-8 treated to different concentrations and exposing periods of EGCG in exponentially growing cultures. The stress shock proteins (70-kDa DnaK and 60-kDa GroEL), which might contribute to enhancing the cellular resistance to the cytotoxic effect of EGCG, were induced at different concentrations of EGCG exposed to cell culture of MH-8. Scanning electron microscopic analysis demonstrated the presence of irregular rod shapes with umbilicated surfaces for cells treated with EGCG. 2-DE of soluble protein fractions from MH-8 cultures showed 18 protein spots changed by EGCG exposure. These proteins involved in chaperons (e.g., DnaK, GroEL and trigger factor), enterotoxins (e.g., aerolysin and phospholipase C precursor), LPS synthesis (e.g., LPS biosynthesis protein and outer membrane protein A precursor), and various biosynthesis and energy metabolism were identified by peptide mass fingerprinting using MALDI-TOF. In consequence, EGCG was found to have substantial antibacterial effects against food-poisoning causing bacterium, hemolytic Aeromonas sp. MH-8. Also the results provide clues for understanding the mechanism of EGCG-induced stress and cytotoxicity on Aeromonas sp. MH-8.

• KSBB Journal
• /
• 제7권1호
• /
• pp.45-50
• /
• 1992

항체 유도 염증 반응인 항체 매개형 과민 반응과 지연형 과민 반응은 족척 두께가 다당류에 의해 거의 정상 수준까지 회복되었다. anilline으로 유도한 methemoglobin의 함량도 거의 차이가 없었다. PFC/spleen cell과 PEC/$10^5$ slpeen cell의 경우 다소 증가를 나타내었으나, PEC는 뚜렷한 증가나 감소를 나타내지 않았으며, 적혈구 응집소가는 다소 증가하였으나 적혈구 용혈소가는 거의 차이가 없었다. 마우스의 plasma corticosterone의 농도는 사육실 및 다당류 투여에 따른 stress요소는 거의 없었다.

• 한국생물물리학회:학술대회논문집
• /
• 한국생물물리학회 2002년도 제9회 학술 발표회 프로그램과 논문초록
• /
• pp.41-41
• /
• 2002

Tolaasin, a pore-forming 1.9 kDa peptide toxin released by Pseudomonas tolaasii, produces brown blotch disease on cultivated oyster mushrooms. To investigate the mechanism of tolaasin-induced cell disruption, we studied the effect of temperature on the hemolytic process. In the kinetic analyses, single exponential function was fitted to the data obtained from temperature-dependent velocity of hemolysis(1/t$\_$50/, implying that there is a major time-limiting factor on the temperature-dependent hemolysis.(omitted)